Northwest Biotherapeutics Company
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Technology:
Dendritic Cells
Industry:
Dendritic Cells
Headquarters:
Bethesda, Maryland, United States
Founded Date:
1998-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
1
Total Funding:
22447154
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-11-22
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership